BioCentury
ARTICLE | Distillery Therapeutics

Hepatic

January 8, 2018 9:49 PM UTC

Mouse and monkey studies suggest promoting CYLD expression could help treat non-alcoholic fatty liver disease (NAFLD) and NASH. In mouse models of diet-induced NAFLD and NASH, CYLD overexpression in h...